30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Somaxon Pharmaceuticals, Inc. (SOMX)

Stock chart
Ticker: SOMX


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Nguyen Tran
SVP and CFO
1 sale — total 1,269 USD
Planned sale 2 Jan 2013
Value US$2,543,574.31 | Price 197.66 | Shares 16,008
Sale 5 Sep 2012
Value US$217,608.17 | Price 341.02 | Shares 32,189
Sale 9 Jul 2012
Value US$498,744.22 | Price 0.31 | Shares 1,624,574
Sale 9 Jul 2012
Value US$498,744.22 | Price 0.31 | Shares 1,624,574
Sale 6 Jul 2012
Value US$195,324.15 | Price 0.29 | Shares 671,217
Sale 6 Jul 2012
Value US$195,324.15 | Price 0.29 | Shares 671,217
Sale 3 Jul 2012
Value US$28,480.90 | Price 0.29 | Shares 98,210
Sale 2 Jul 2012
Value US$28,480.90 | Price 0.29 | Shares 98,210
Sale 2 Jul 2012
Value US$23,300.92 | Price 0.29 | Shares 80,348
Sale 2 Jul 2012
Value US$23,300.92 | Price 0.29 | Shares 80,348
Sale 28 Jun 2012
Value US$5,655.00 | Price 0.29 | Shares 19,500
Sale 28 Jun 2012
Value US$5,655.00 | Price 0.29 | Shares 19,500
Sale 19 Jun 2012
Value US$3,480.00 | Price 0.29 | Shares 12,000
Sale 19 Jun 2012
Value US$3,480.00 | Price 0.29 | Shares 12,000
Sale 15 Jun 2012
Value US$420.50 | Price 0.29 | Shares 1,450
Sale 15 Jun 2012
Value US$420.50 | Price 0.29 | Shares 1,450
Sale 6 Jun 2012
Value US$2,436.00 | Price 0.29 | Shares 8,400
Sale 6 Jun 2012
Value US$2,436.00 | Price 0.29 | Shares 8,400
Sale 5 Jun 2012
Value US$8,570.95 | Price 0.29 | Shares 29,555
Sale 5 Jun 2012
Value US$8,570.95 | Price 0.29 | Shares 29,555
Sale 31 May 2012
Value US$8,955.00 | Price 0.30 | Shares 29,850
Sale 31 May 2012
Value US$8,955.00 | Price 0.30 | Shares 29,850
Sale 30 May 2012
Value US$15,302.10 | Price 0.30 | Shares 51,007
Sale 30 May 2012
Value US$15,302.10 | Price 0.30 | Shares 51,007
Sale 29 May 2012
Value US$4,622.13 | Price 0.30 | Shares 15,300
Sale 29 May 2012
Value US$4,622.13 | Price 0.30 | Shares 15,300
Sale 25 May 2012
Value US$87,904.50 | Price 0.30 | Shares 293,015
Sale 25 May 2012
Value US$87,904.50 | Price 0.30 | Shares 293,015
Sale 23 May 2012
Value US$40,629.10 | Price 0.30 | Shares 135,250
Sale 23 May 2012
Value US$40,629.10 | Price 0.30 | Shares 135,250
Sale 22 May 2012
Value US$86,989.70 | Price 0.30 | Shares 287,000
Sale 22 May 2012
Value US$86,989.70 | Price 0.30 | Shares 287,000
Buy 10 Jun 2011
Value US$24,942.81 | Price 2.25 | Shares 11,100
Sale 3 Jan 2011
Value US$32,340.00 | Price 3.23 | Shares 10,000
Buy 15 Sep 2010
Value US$9,725.00 | Price 3.89 | Shares 2,500
Planned sale 1 Sep 2010
Value US$12,810.00 | Price 4.27 | Shares 3,000
Planned sale 25 Aug 2010
Value US$24,950.00 | Price 4.99 | Shares 5,000
Planned sale 10 Aug 2010
Value US$11,970.00 | Price 3.99 | Shares 3,000
Planned sale 15 Jul 2010
Value US$11,970.00 | Price 3.99 | Shares 3,000
Planned sale 24 Jun 2010
Value US$17,012.61 | Price 4.48 | Shares 3,795
Planned sale 24 Jun 2010
Value US$6,240.20 | Price 4.48 | Shares 1,392
Planned sale 24 Jun 2010
Value US$8,217.16 | Price 4.48 | Shares 1,833
Planned sale 24 Jun 2010
Value US$6,329.85 | Price 4.48 | Shares 1,412
Planned sale 24 Jun 2010
Value US$1,586.95 | Price 4.48 | Shares 354
Planned sale 24 Jun 2010
Value US$959.34 | Price 4.48 | Shares 214
Planned sale 18 Mar 2010
Value US$4,867.50 | Price 9.74 | Shares 500
Planned sale 18 Mar 2010
Value US$24,596.04 | Price 8.78 | Shares 2,800
Planned sale 18 Mar 2010
Value US$125,947.08 | Price 7.92 | Shares 15,900
Planned sale 18 Mar 2010
Value US$105,322.80 | Price 6.67 | Shares 15,800
Planned sale 18 Mar 2010
Value US$120,262.40 | Price 5.23 | Shares 23,000
Planned sale 18 Mar 2010
Value US$130,086.00 | Price 9.00 | Shares 14,454
Planned sale 18 Mar 2010
Value US$98,881.50 | Price 6.59 | Shares 15,000
Sale 18 Mar 2010
Value US$9,573,600.00 | Price 6.38 | Shares 1,500,000
Sale 18 Mar 2010
Value US$11,682.00 | Price 9.74 | Shares 1,200
Sale 18 Mar 2010
Value US$60,003.88 | Price 8.82 | Shares 6,800
Sale 18 Mar 2010
Value US$58,821.75 | Price 7.84 | Shares 7,500
Sale 18 Mar 2010
Value US$161,053.20 | Price 6.57 | Shares 24,500
Planned sale 18 Mar 2010
Value US$2,243.40 | Price 9.75 | Shares 230
Planned sale 18 Mar 2010
Value US$18,571.35 | Price 8.84 | Shares 2,100
Planned sale 18 Mar 2010
Value US$18,753.12 | Price 7.81 | Shares 2,400
Sale 18 Mar 2010
Value US$11,490.96 | Price 9.58 | Shares 1,200
Sale 18 Mar 2010
Value US$22,719.06 | Price 8.74 | Shares 2,600
Sale 18 Mar 2010
Value US$36,156.00 | Price 7.53 | Shares 4,800
Sale 18 Mar 2010
Value US$96,928.41 | Price 6.42 | Shares 15,100
Sale 18 Mar 2010
Value US$429,111.20 | Price 5.62 | Shares 76,300
Planned sale 1 Mar 2010
Value US$342,367.20 | Price 4.08 | Shares 84,000
Planned sale 1 Mar 2010
Value US$160,524.00 | Price 4.01 | Shares 40,000
Planned sale 1 Mar 2010
Value US$120,465.00 | Price 4.02 | Shares 30,000
Planned sale 1 Mar 2010
Value US$92,179.40 | Price 4.01 | Shares 23,000
Planned sale 26 Feb 2010
Value US$23,940.00 | Price 3.99 | Shares 6,000
Planned sale 5 Feb 2010
Value US$63,368.36 | Price 3.06 | Shares 20,712
Planned sale 5 Feb 2010
Value US$174,305.50 | Price 3.03 | Shares 57,500
Planned sale 5 Feb 2010
Value US$187,599.60 | Price 3.03 | Shares 62,000
Planned sale 5 Feb 2010
Value US$181,506.00 | Price 3.03 | Shares 60,000
Sale 18 Dec 2009
Value US$67,438.80 | Price 1.10 | Shares 61,308
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2013-01-03 2013-01-02 PlS Planned sale Nguyen Tran

SVP and CFO

Officer
16,008 +16.3%
197.66
US$2,543,574
16,008 +16.3% 197.66 US$2,543,574
2012-09-06 2012-09-05 S Sale EMSTER KURT VON Non-Executive Director
32,189 -9.6%
341.02
US$217,608
32,189 -9.6% 341.02 US$217,608
2012-07-10 2012-07-09 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
52,078 +28.4%
448.35
US$4,845,125
52,078 +28.4% 448.35 US$4,845,125
2012-07-10 2012-07-09 S Sale EVNIN LUKE Large shareholder
1,624,574 -56.0%
0.31
US$498,744
1,624,574 -56.0% 0.31 US$498,744
2012-07-10 2012-07-06 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
671,217 -18.8%
0.29
US$195,324
671,217 -18.8% 0.29 US$195,324
2012-07-10 2012-07-06 S Sale EVNIN LUKE Large shareholder
671,217 -18.8%
0.29
US$195,324
671,217 -18.8% 0.29 US$195,324
2012-07-05 2012-07-03 S Sale EVNIN LUKE Large shareholder
98,210 -2.7%
0.29
US$28,481
98,210 -2.7% 0.29 US$28,481
2012-07-05 2012-07-02 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
98,210 -2.7%
0.29
US$28,481
98,210 -2.7% 0.29 US$28,481
2012-07-05 2012-07-02 S Sale EVNIN LUKE Large shareholder
80,348 -2.1%
0.29
US$23,301
80,348 -2.1% 0.29 US$23,301
2012-07-05 2012-07-02 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
80,348 -2.1%
0.29
US$23,301
80,348 -2.1% 0.29 US$23,301
2012-07-02 2012-06-28 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
19,500 -0.5%
0.29
US$5,655
19,500 -0.5% 0.29 US$5,655
2012-07-02 2012-06-28 S Sale EVNIN LUKE Large shareholder
19,500 -0.5%
0.29
US$5,655
19,500 -0.5% 0.29 US$5,655
2012-06-21 2012-06-19 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
12,000 -0.3%
0.29
US$3,480
12,000 -0.3% 0.29 US$3,480
2012-06-21 2012-06-19 S Sale EVNIN LUKE Large shareholder
12,000 -0.3%
0.29
US$3,480
12,000 -0.3% 0.29 US$3,480
2012-06-19 2012-06-15 S Sale EVNIN LUKE Large shareholder
1,450 -0.0%
0.29
US$420
1,450 -0.0% 0.29 US$420
2012-06-19 2012-06-15 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
1,450 -0.0%
0.29
US$420
1,450 -0.0% 0.29 US$420
2012-06-07 2012-06-06 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
8,400 -0.2%
0.29
US$2,436
8,400 -0.2% 0.29 US$2,436
2012-06-07 2012-06-06 S Sale EVNIN LUKE Large shareholder
8,400 -0.2%
0.29
US$2,436
8,400 -0.2% 0.29 US$2,436
2012-06-07 2012-06-05 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
29,555 -0.8%
0.29
US$8,571
29,555 -0.8% 0.29 US$8,571
2012-06-07 2012-06-05 S Sale EVNIN LUKE Large shareholder
29,555 -0.8%
0.29
US$8,571
29,555 -0.8% 0.29 US$8,571
2012-06-04 2012-05-31 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
29,850 -0.8%
0.30
US$8,955
29,850 -0.8% 0.30 US$8,955
2012-06-04 2012-05-31 S Sale EVNIN LUKE Large shareholder
29,850 -0.8%
0.30
US$8,955
29,850 -0.8% 0.30 US$8,955
2012-06-04 2012-05-30 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
51,007 -1.3%
0.30
US$15,302
51,007 -1.3% 0.30 US$15,302
2012-06-04 2012-05-30 S Sale EVNIN LUKE Large shareholder
51,007 -1.3%
0.30
US$15,302
51,007 -1.3% 0.30 US$15,302
2012-06-04 2012-05-29 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
15,300 -0.4%
0.30
US$4,622
15,300 -0.4% 0.30 US$4,622
2012-06-04 2012-05-29 S Sale EVNIN LUKE Large shareholder
15,300 -0.4%
0.30
US$4,622
15,300 -0.4% 0.30 US$4,622
2012-06-04 2012-05-25 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
293,015 -7.0%
0.30
US$87,904
293,015 -7.0% 0.30 US$87,904
2012-06-04 2012-05-25 S Sale EVNIN LUKE Large shareholder
293,015 -7.0%
0.30
US$87,904
293,015 -7.0% 0.30 US$87,904
2012-06-04 2012-05-23 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
135,250 -3.1%
0.30
US$40,629
135,250 -3.1% 0.30 US$40,629
2012-06-04 2012-05-23 S Sale EVNIN LUKE Large shareholder
135,250 -3.1%
0.30
US$40,629
135,250 -3.1% 0.30 US$40,629
2012-06-04 2012-05-22 S Sale MPM BIOVENTURES III-QP L.P. Large shareholder
287,000 -6.2%
0.30
US$86,990
287,000 -6.2% 0.30 US$86,990
2012-06-04 2012-05-22 S Sale EVNIN LUKE Large shareholder
287,000 -6.2%
0.30
US$86,990
287,000 -6.2% 0.30 US$86,990
2011-06-13 2011-06-10 B Purchase Pascoe Richard W

President and CEO

Executive Director
11,100 +5.6%
2.25
US$24,943
11,100 +5.6% 2.25 US$24,943
2011-01-05 2011-01-03 S Sale MAST ERLE T Non-Executive Director
10,000 -15.0%
3.23
US$32,340
10,000 -15.0% 3.23 US$32,340
2010-09-15 2010-09-15 B Purchase Nguyen Tran

Vice President and CFO

Officer
2,500 +10.0%
3.89
US$9,725
2,500 +10.0% 3.89 US$9,725
2010-09-03 2010-09-01 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
3,000 -5.5%
4.27
US$12,810
3,000 -5.5% 4.27 US$12,810
2010-08-27 2010-08-25 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
5,000 -8.8%
4.99
US$24,950
5,000 -8.8% 4.99 US$24,950
2010-08-13 2010-08-10 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
3,000 -5.5%
3.99
US$11,970
3,000 -5.5% 3.99 US$11,970
2010-07-16 2010-07-15 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
3,000 -5.5%
3.99
US$11,970
3,000 -5.5% 3.99 US$11,970
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
3,795 -100.0%
4.48
US$17,013
3,795 -100.0% 4.48 US$17,013
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
1,392 -100.0%
4.48
US$6,240
1,392 -100.0% 4.48 US$6,240
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
1,833 -100.0%
4.48
US$8,217
1,833 -100.0% 4.48 US$8,217
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
1,412 -100.0%
4.48
US$6,330
1,412 -100.0% 4.48 US$6,330
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
354 -100.0%
4.48
US$1,587
354 -100.0% 4.48 US$1,587
2010-06-25 2010-06-24 PlS Planned sale Dorsey Brian

SVP, Technical Operations

Officer
214 -100.0%
4.48
US$959
214 -100.0% 4.48 US$959
2010-03-22 2010-03-18 PlS Planned sale Dorsey Brian

VP Product Development

Officer
500 -5.0%
9.74
US$4,868
500 -5.0% 9.74 US$4,868
2010-03-22 2010-03-18 PlS Planned sale Dorsey Brian

VP Product Development

Officer
2,800 -22.0%
8.78
US$24,596
2,800 -22.0% 8.78 US$24,596
2010-03-22 2010-03-18 PlS Planned sale Dorsey Brian

VP Product Development

Officer
15,900 -55.6%
7.92
US$125,947
15,900 -55.6% 7.92 US$125,947
2010-03-22 2010-03-18 PlS Planned sale Dorsey Brian

VP Product Development

Officer
15,800 -35.6%
6.67
US$105,323
15,800 -35.6% 6.67 US$105,323
2010-03-22 2010-03-18 PlS Planned sale Dorsey Brian

VP Product Development

Officer
23,000 -34.1%
5.23
US$120,262
23,000 -34.1% 5.23 US$120,262
2010-03-22 2010-03-18 PlS Planned sale Onaitis Matthew

VP, General Counsel

Officer
14,454 -32.5%
9.00
US$130,086
14,454 -32.5% 9.00 US$130,086
2010-03-22 2010-03-18 PlS Planned sale Onaitis Matthew

VP, General Counsel

Officer
15,000 -25.2%
6.59
US$98,882
15,000 -25.2% 6.59 US$98,882
2010-03-22 2010-03-18 S Sale MONTREUX EQUITY PARTNERS II SBIC LP Large shareholder
1,500,000 -68.3%
6.38
US$9,573,600
1,500,000 -68.3% 6.38 US$9,573,600
2010-03-19 2010-03-18 S Sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
1,200 -7.4%
9.74
US$11,682
1,200 -7.4% 9.74 US$11,682
2010-03-19 2010-03-18 S Sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
6,800 -29.6%
8.82
US$60,004
6,800 -29.6% 8.82 US$60,004
2010-03-19 2010-03-18 S Sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
7,500 -24.6%
7.84
US$58,822
7,500 -24.6% 7.84 US$58,822
2010-03-19 2010-03-18 S Sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
24,500 -44.5%
6.57
US$161,053
24,500 -44.5% 6.57 US$161,053
2010-03-19 2010-03-18 PlS Planned sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
230 -1.5%
9.75
US$2,243
230 -1.5% 9.75 US$2,243
2010-03-19 2010-03-18 PlS Planned sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
2,100 -12.1%
8.84
US$18,571
2,100 -12.1% 8.84 US$18,571
2010-03-19 2010-03-18 PlS Planned sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
2,400 -12.2%
7.81
US$18,753
2,400 -12.2% 7.81 US$18,753
2010-03-19 2010-03-18 S Sale Pascoe Richard W

President and CEO

Executive Director
1,200 -7.2%
9.58
US$11,491
1,200 -7.2% 9.58 US$11,491
2010-03-19 2010-03-18 S Sale Pascoe Richard W

President and CEO

Executive Director
2,600 -13.5%
8.74
US$22,719
2,600 -13.5% 8.74 US$22,719
2010-03-19 2010-03-18 S Sale Pascoe Richard W

President and CEO

Executive Director
4,800 -19.9%
7.53
US$36,156
4,800 -19.9% 7.53 US$36,156
2010-03-19 2010-03-18 S Sale Pascoe Richard W

President and CEO

Executive Director
15,100 -38.5%
6.42
US$96,928
15,100 -38.5% 6.42 US$96,928
2010-03-19 2010-03-18 S Sale Pascoe Richard W

President and CEO

Executive Director
76,300 -66.1%
5.62
US$429,111
76,300 -66.1% 5.62 US$429,111
2010-03-03 2010-03-01 PlS Planned sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
84,000 -100.0%
4.08
US$342,367
84,000 -100.0% 4.08 US$342,367
2010-03-03 2010-03-01 PlS Planned sale Pascoe Richard W

President and CEO

Executive Director
40,000 -100.0%
4.01
US$160,524
40,000 -100.0% 4.01 US$160,524
2010-03-03 2010-03-01 PlS Planned sale Onaitis Matthew

VP, General Counsel

Officer
30,000 -100.0%
4.02
US$120,465
30,000 -100.0% 4.02 US$120,465
2010-03-02 2010-03-01 PlS Planned sale Dorsey Brian

VP Product Development

Officer
23,000 -100.0%
4.01
US$92,179
23,000 -100.0% 4.01 US$92,179
2010-03-02 2010-02-26 PlS Planned sale Dorsey Brian

VP Product Development

Officer
6,000 -100.0%
3.99
US$23,940
6,000 -100.0% 3.99 US$23,940
2010-02-09 2010-02-05 PlS Planned sale Dorsey Brian

VP Product Development

Officer
20,712 -100.0%
3.06
US$63,368
20,712 -100.0% 3.06 US$63,368
2010-02-09 2010-02-05 PlS Planned sale Raser Jeffrey

Senior VP, Sales and Marketing

Officer
57,500 -100.0%
3.03
US$174,306
57,500 -100.0% 3.03 US$174,306
2010-02-09 2010-02-05 PlS Planned sale Pascoe Richard W

President and CEO

Executive Director
62,000 -100.0%
3.03
US$187,600
62,000 -100.0% 3.03 US$187,600
2010-02-09 2010-02-05 PlS Planned sale Onaitis Matthew

VP, General Counsel

Officer
60,000 -100.0%
3.03
US$181,506
60,000 -100.0% 3.03 US$181,506
2009-12-18 2009-12-18 S Sale TREU JESSE I Non-Executive Director
61,308 -100.0%
1.10
US$67,439
61,308 -100.0% 1.10 US$67,439
Explore more

More insider trading research around Somaxon Pharmaceuticals, Inc.